Amanda Haas

Business Development Manager, Nucleic Acid Solutions

Agilent Technologies

Andrew Anzalone

Director, Head of Prime Editing Platform

Prime Medicine

Ankit Gupta

Senior Director, Head of Gene Editing

Affini-T Therapeutics

Apiwat Wangweerawong

Director, Delivery Chemistry

Tessera Therapeutics

Barrett Nuttall

Director

AstraZeneca

Britta Jones

Senior Scientist

Tune Therapeutics

Bryant Chica

Scientist II, Analytical Chemistry & Structural Biology

Editas Medicine

Carlo Zambonelli

Independent LNP Expert

Christina Jordan

Senior Director, Intellectual Property

Tune Therapeutics

Claire Levée

Director, Regulatory Affairs, Genetic Medicine

Regeneron Pharmaceuticals

Dave Carter

Senior Director, Head of Research

Evox Therapeutics

Eneda Hoxha

Vice President - Intellectual Property & Business Development

ReCode Therapeutics

Jason Lehmann

Senior Product Marketing Manager

CRISPR QC

Jeffrey Cehelsky

VP Development Operations

Intellia Therapeutics

Jeffrey Marshall

Analytical Director, mRNA & gRNA Platforms

Beam Therapeutics

John Murphy

Chief Scientific Officer

Arbor Biotechnologies

Jordanna Mora

se

Beam Therapeutics

Joseph Nabhan

Chief Scientific Officer

Vesigen Therapeutics

Kiran Musunuru

Professor

University of Pennsylvania

Luca Biasco

Vice President

Nvelop Therapeutics

Marco Weinberg

Senior Vice President, Head of Research

ReCode Therapeutics, Inc

Mark DeWitt

Associate Director

Mammoth Biosciences

Max Sellman

Senior Product Manager, Gene Editing

Aldevron

Narin Ahmed

Vice President, Regulatory Science

Tessera Therapeutics

Omid Harandi

Chief Scientific Officer

Komo Biosciences

Priya Chockalingam

Vice President, Head of Clinical Bioanalytics & Translational Sciences

Beam Therapeutics

Ryan Leenay

Associate Vice President, Genome Editing

Eli Lilly & Co.

Ryo Takeuchi

Senior Director, Genome Editing

Excision BioTherapeutics Inc.

Safi Shahda

Senior Director

Intellia Therapeutics

Sam Sternberg (VIRTUAL)

Assistant Professor, Department of Biochemistry & Molecular Biophysics

Columbia University

Shane Wright

Associate Scientist II

Chroma Medicine

Sheryl Bowley

Director, HSC Therapies

Editas Medicine

Tetsuya Yamagata

Chief Scientific Officer

Modalis Therapeutics

TJ Cradick

Chief Technology Officer

HuidaGene Therapeutics

Tobias Brambrink

Vice President, Legal & Intellectual Property

Chroma Medicine

Vivian Choi

Head of Liver, Metabolic, Lung, Eye & Ear Disease Unit

Prime Medicine